[HTML][HTML] Evidence of epigenetic landscape shifts in mucopolysaccharidosis IIIB and IVA

V Vargas-López, LF Prada, CJ Alméciga-Díaz - Scientific Reports, 2024 - nature.com
Lysosomal storage diseases (LSDs) are a group of monogenic diseases characterized by
mutations in genes coding for proteins associated with the lysosomal function. Despite the …

[HTML][HTML] Disease pathology signatures in a mouse model of Mucopolysaccharidosis type IIIB

R Petrova, AR Patil, V Trinh, KE McElroy, M Bhakta… - Scientific Reports, 2023 - nature.com
Abstract Mucopolysaccharidosis type IIIB (MPS IIIB) is a rare and devastating childhood-
onset lysosomal storage disease caused by complete loss of function of the lysosomal …

[HTML][HTML] Underestimated aspect of mucopolysaccharidosis pathogenesis: global changes in cellular processes revealed by transcriptomic studies

L Gaffke, K Pierzynowska, M Podlacha… - International Journal of …, 2020 - mdpi.com
Mucopolysaccharidoses (MPS), a group of inherited metabolic disorders caused by
deficiency in enzymes involved in degradation of glycosaminoglycans (GAGs), are …

[HTML][HTML] Molecular characterization of a novel splicing mutation underlying mucopolysaccharidosis (MPS) type VI—Indirect proof of principle on its pathogenicity

MF Coutinho, M Encarnação, L Matos, L Silva… - Diagnostics, 2020 - mdpi.com
Here, we present the molecular diagnosis of a patient with a general clinical suspicion of
Mucopolysaccharidosis, highlighting the different tools used to perform its molecular …

[PDF][PDF] Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB

M Scarcella, G Scerra, M Ciampa, M Caterino… - Iscience, 2024 - cell.com
Mucopolysaccharidoses (MPSs) are lysosomal disorders with neurological involvement for
which no cure exists. Here, we show that recombinant NK1 fragment of hepatocyte growth …

Diagnosis of patients with mucopolysaccharidosis type II via RNA sequencing

J Tang, G Chang, M Wei, X Li, H Chen, Y Qin… - Clinica Chimica …, 2022 - Elsevier
Abstract Background Mucopolysaccharidosis type II (MPS II) is an X-linked recessive
lysosomal storage disorder caused by various variants in the IDS gene. It is known that …

[HTML][HTML] Transcriptomic changes related to cellular processes with particular emphasis on cell activation in lysosomal storage diseases from the group of …

E Rintz, L Gaffke, M Podlacha, J Brokowska… - International Journal of …, 2020 - mdpi.com
Although mucopolysaccharidoses (MPS), inherited metabolic diseases from the group of
lysosomal storage diseases (LSD), are monogenic disorders, recent studies indicated that …

Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry

LA Clarke, R Giugliani, N Guffon, SA Jones… - Clinical …, 2019 - Wiley Online Library
Abstract Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disorder
resulting from pathogenic variants in the α‐L‐iduronidase (IDUA) gene. Clinical phenotypes …

From bedside to cell biology: a century of history on lysosomal dysfunction

MF Coutinho, L Matos, S Alves - Gene, 2015 - Elsevier
Lysosomal storage disorders (LSDs) are a group of rare genetic diseases, generally caused
by a deficiency of specific lysosomal enzymes, which results in abnormal accumulation of …

[HTML][HTML] Mucopolysaccharidosis type I: current treatments, limitations, and prospects for improvement

CS Hampe, J Wesley, TC Lund, PJ Orchard… - Biomolecules, 2021 - mdpi.com
Mucopolysaccharidosis type I (MPS I) is a lysosomal disease, caused by a deficiency of the
enzyme alpha-L-iduronidase (IDUA). IDUA catalyzes the degradation of the …